Selected research
Industry Growth & Trends
Global Dried Blood Spot (DBS) Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Dried Blood Spot (DBS) Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Dried Blood Spot (DBS) Testing market include ZRT Laboratory, Randox Laboratories, RDA Spot, Lipomic, CRL, HemaXis, EUROIMMUN, Boston Heart Diagnostics and Kurukankarti, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dried Blood Spot (DBS) Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dried Blood Spot (DBS) Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dried Blood Spot (DBS) Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dried Blood Spot (DBS) Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Dried Blood Spot (DBS) Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dried Blood Spot (DBS) Testing Market by Company
ZRT Laboratory
Randox Laboratories
RDA Spot
Lipomic
CRL
HemaXis
EUROIMMUN
Boston Heart Diagnostics
Kurukankarti
Capitainer
Dried Blood Spot (DBS) Testing Segment by Type
Testing Card
Testing Kit
Dried Blood Spot (DBS) Testing Segment by Application
HIV Test
Hepatitis C Test
Others
Dried Blood Spot (DBS) Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dried Blood Spot (DBS) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dried Blood Spot (DBS) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dried Blood Spot (DBS) Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dried Blood Spot (DBS) Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Testing Card
- Testing Kit
Applications
- HIV Test
- Hepatitis C Test
- Others
Companies covered
- ZRT Laboratory
- Randox Laboratories
- RDA Spot
- Lipomic
- CRL
- HemaXis
- EUROIMMUN
- Boston Heart Diagnostics
- Kurukankarti
- Capitainer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Dried Blood Spot (DBS) Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Dried Blood Spot (DBS) Testing Market Size by Region (2021-2032)
- 1.4.1 Global Dried Blood Spot (DBS) Testing Market Size by Region (2021-2026)
- 1.4.2 Global Dried Blood Spot (DBS) Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 1.5.1 North America Dried Blood Spot (DBS) Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Dried Blood Spot (DBS) Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Dried Blood Spot (DBS) Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size Growth Rate (2021-2032)
2 Dried Blood Spot (DBS) Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Testing Card
- 2.1.2 Testing Kit
- 2.2 Global Dried Blood Spot (DBS) Testing Market Size by Type
- 2.2.1 Global Dried Blood Spot (DBS) Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Dried Blood Spot (DBS) Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Dried Blood Spot (DBS) Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Dried Blood Spot (DBS) Testing Market Size by Regions
- 2.3.1 North America Dried Blood Spot (DBS) Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Dried Blood Spot (DBS) Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Dried Blood Spot (DBS) Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Dried Blood Spot (DBS) Testing Market Size Breakdown by Type (2021-2026)
3 Dried Blood Spot (DBS) Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 HIV Test
- 3.1.2 Hepatitis C Test
- 3.1.3 Others
- 3.2 Global Dried Blood Spot (DBS) Testing Market Size by Application
- 3.2.1 Global Dried Blood Spot (DBS) Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Dried Blood Spot (DBS) Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Dried Blood Spot (DBS) Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Dried Blood Spot (DBS) Testing Market Size by Regions
- 3.3.1 North America Dried Blood Spot (DBS) Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Dried Blood Spot (DBS) Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Dried Blood Spot (DBS) Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Dried Blood Spot (DBS) Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Dried Blood Spot (DBS) Testing Industry Trends
- 4.2 Dried Blood Spot (DBS) Testing Industry Drivers
- 4.3 Dried Blood Spot (DBS) Testing Industry Opportunities and Challenges
- 4.4 Dried Blood Spot (DBS) Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Dried Blood Spot (DBS) Testing Revenue (2021-2026)
- 5.2 Global Dried Blood Spot (DBS) Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Dried Blood Spot (DBS) Testing Key Company Headquarters & Area Served
- 5.4 Global Dried Blood Spot (DBS) Testing Company, Product Type & Application
- 5.5 Global Dried Blood Spot (DBS) Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Dried Blood Spot (DBS) Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Dried Blood Spot (DBS) Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Dried Blood Spot (DBS) Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ZRT Laboratory
- 6.1.1 ZRT Laboratory Company Information
- 6.1.2 ZRT Laboratory Business Overview
- 6.1.3 ZRT Laboratory Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio
- 6.1.5 ZRT Laboratory Recent Developments
- 6.2 Randox Laboratories
- 6.2.1 Randox Laboratories Company Information
- 6.2.2 Randox Laboratories Business Overview
- 6.2.3 Randox Laboratories Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio
- 6.2.5 Randox Laboratories Recent Developments
- 6.3 RDA Spot
- 6.3.1 RDA Spot Company Information
- 6.3.2 RDA Spot Business Overview
- 6.3.3 RDA Spot Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio
- 6.3.5 RDA Spot Recent Developments
- 6.4 Lipomic
- 6.4.1 Lipomic Company Information
- 6.4.2 Lipomic Business Overview
- 6.4.3 Lipomic Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lipomic Dried Blood Spot (DBS) Testing Product Portfolio
- 6.4.5 Lipomic Recent Developments
- 6.5 CRL
- 6.5.1 CRL Company Information
- 6.5.2 CRL Business Overview
- 6.5.3 CRL Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CRL Dried Blood Spot (DBS) Testing Product Portfolio
- 6.5.5 CRL Recent Developments
- 6.6 HemaXis
- 6.6.1 HemaXis Company Information
- 6.6.2 HemaXis Business Overview
- 6.6.3 HemaXis Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 HemaXis Dried Blood Spot (DBS) Testing Product Portfolio
- 6.6.5 HemaXis Recent Developments
- 6.7 EUROIMMUN
- 6.7.1 EUROIMMUN Company Information
- 6.7.2 EUROIMMUN Business Overview
- 6.7.3 EUROIMMUN Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio
- 6.7.5 EUROIMMUN Recent Developments
- 6.8 Boston Heart Diagnostics
- 6.8.1 Boston Heart Diagnostics Company Information
- 6.8.2 Boston Heart Diagnostics Business Overview
- 6.8.3 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio
- 6.8.5 Boston Heart Diagnostics Recent Developments
- 6.9 Kurukankarti
- 6.9.1 Kurukankarti Company Information
- 6.9.2 Kurukankarti Business Overview
- 6.9.3 Kurukankarti Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio
- 6.9.5 Kurukankarti Recent Developments
- 6.10 Capitainer
- 6.10.1 Capitainer Company Information
- 6.10.2 Capitainer Business Overview
- 6.10.3 Capitainer Dried Blood Spot (DBS) Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Capitainer Dried Blood Spot (DBS) Testing Product Portfolio
- 6.10.5 Capitainer Recent Developments
7 North America
- 7.1 North America Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 7.3 North America Dried Blood Spot (DBS) Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 8.3 Europe Dried Blood Spot (DBS) Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 10.3 South America Dried Blood Spot (DBS) Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst